{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:52:23Z","timestamp":1770537143245,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.expneurol.2005.03.006","type":"journal-article","created":{"date-parts":[[2005,5,25]],"date-time":"2005-05-25T11:44:44Z","timestamp":1117021484000},"page":"49-60","source":"Crossref","is-referenced-by-count":71,"title":["Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct"],"prefix":"10.1016","volume":"195","author":[{"given":"Lone","family":"Fjord-Larsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Leander","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Kusk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Torn\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Gr\u00f8nborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Rosenblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars U.","family":"Wahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2005.03.006_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1471-4159.1999.0730070.x","article-title":"Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons","volume":"73","author":"Akerud","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.03.006_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0959-4388(99)00048-3","article-title":"The GDNF family ligands and receptors\u2014Implications for neural development","volume":"10","author":"Baloh","year":"2000","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/exnr.2000.7409","article-title":"Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF","volume":"164","author":"Bensadoun","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib4","doi-asserted-by":"crossref","first-page":"8818","DOI":"10.1073\/pnas.94.16.8818","article-title":"Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease","volume":"94","author":"Bilang-bleuel","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2005.03.006_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0896-6273(00)80514-0","article-title":"GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney","volume":"21","author":"Cacalano","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2005.03.006_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/exnr.2001.7638","article-title":"Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration","volume":"169","author":"Connor","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.expneurol.2005.03.006_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/exnr.2002.8006","article-title":"Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer","volume":"177","author":"Georgievska","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00001756-200201210-00019","article-title":"Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector","volume":"13","author":"Georgievska","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2005.03.006_bib10","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1523\/JNEUROSCI.1122-04.2004","article-title":"Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system","volume":"24","author":"Georgievska","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2","article-title":"Expression of neurturin, GDNF, and their receptors in the adult mouse CNS","volume":"398","author":"Golden","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.2315700","article-title":"Requirement for activin A and transforming growth factor-beta 1 pro-regions in homodimer assembly","volume":"247","author":"Gray","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2005.03.006_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/exnr.1999.7175","article-title":"Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor","volume":"160","author":"Hoane","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib14","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1523\/JNEUROSCI.18-13-04929.1998","article-title":"Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons","volume":"18","author":"Horger","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib15","doi-asserted-by":"crossref","first-page":"33111","DOI":"10.1074\/jbc.272.52.33111","article-title":"GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family","volume":"272","author":"Jing","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2005.03.006_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib17","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1523\/JNEUROSCI.20-12-04686.2000","article-title":"Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system","volume":"20","author":"Kirik","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.0953-816x.2001.01534.x","article-title":"Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease","volume":"13","author":"Kirik","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/42722","article-title":"A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor [published erratum appears in Nature 1998 Mar 12;392(6672):210]","volume":"387","author":"Klein","year":"1997","journal-title":"Nature"},{"issue":"Suppl 3","key":"10.1016\/j.expneurol.2005.03.006_bib20","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1002\/ana.10485","article-title":"In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease","volume":"53","author":"Kordower","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(97)01100-1","article-title":"Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease","volume":"777","author":"Lapchak","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.03.006_bib22","doi-asserted-by":"crossref","first-page":"14083","DOI":"10.1073\/pnas.94.25.14083","article-title":"Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats","volume":"94","author":"Mandel","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2005.03.006_bib23","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/MCB.13.6.3359","article-title":"Sequences within the last intron function in RNA 3\u2032-end formation in cultured cells","volume":"13","author":"Nesic","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1073\/pnas.88.2.478","article-title":"Heterologous introns can enhance expression of transgenes in mice","volume":"88","author":"Palmiter","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2005.03.006_bib40","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.expneurol.2005.03.006_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0092-8674(91)90116-G","article-title":"Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain","volume":"66","author":"Renfranz","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2005.03.006_bib26","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1046\/j.1460-9568.1999.00566.x","article-title":"Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle","volume":"11","author":"Rosenblad","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mcne.1999.0817","article-title":"In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin\/artemin","volume":"15","author":"Rosenblad","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1460-9568.2003.02456.x","article-title":"Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system","volume":"17","author":"Rosenblad","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib29","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1128\/JVI.63.10.4386-4394.1989","article-title":"Simian virus 40 late transcripts lacking excisable intervening sequences are defective in both stability in the nucleus and transport to the cytoplasm","volume":"63","author":"Ryu","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib30","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1073\/pnas.94.12.6238","article-title":"Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins","volume":"94","author":"Sanicola","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2005.03.006_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2005.03.006_bib32","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/j.1460-2075.1991.tb07778.x","article-title":"Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF","volume":"10","author":"Suter","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2005.03.006_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1523\/JNEUROSCI.17-01-00325.1997","article-title":"GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine","volume":"17","author":"Tseng","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib34","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1097\/00001756-199806010-00027","article-title":"Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy","volume":"9","author":"Tseng","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2005.03.006_bib35","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1523\/JNEUROSCI.17-21-08506.1997","article-title":"Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs","volume":"17","author":"Widenfalk","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib36","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1523\/JNEUROSCI.18-12-04684.1998","article-title":"Expression of GDNF family receptor components during development: implications in the mechanisms of interaction","volume":"18","author":"Yu","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.03.006_bib37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib38","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2005.03.006_bib39","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"Zufferey","year":"1999","journal-title":"J. Virol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T11:54:42Z","timestamp":1586260482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488605001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0014488605001093"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2005.03.006","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}